Bionano Genomics, Inc. — Director's Dealing 2018

Aug 27, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioNano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2018-08-23

Reporting Person: Cao Han PHD (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-23	Common Stock	C	5941	—	Acquired	7354	Direct
2018-08-23	Common Stock	C	1231	—	Acquired	8585	Direct
2018-08-23	Common Stock	C	101918	—	Acquired	110503	Direct
2018-08-23	Common Stock	C	2433	—	Acquired	112936	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-08-23	Series B Convertible Preferred Stock	$	C	254275	Disposed		Common Stock (5941)	Direct
2018-08-23	Series C Convertible Preferred Stock	$	C	52720	Disposed		Common Stock (1231)	Direct
2018-08-23	Series D Convertible Preferred Stock	$	C	4362062	Disposed		Common Stock (101918)	Direct
2018-08-23	Series D-1 Convertible Preferred Stock	$	C	104167	Disposed		Common Stock (2433)	Direct

Footnotes

F1: Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-42.8 basis. The shares have no expiration date.